| Renal and Vascular Pathologies | Lifetime | 11 | US 9 | 99.77 |
| MRI in cancer diagnosis | Lifetime | 75 | US 41 | 99.30 |
| Abdominal vascular conditions and treatments | Lifetime | 28 | US 21 | 98.97 |
| Extracellular vesicles in disease | Lifetime | 94 | US 32 | 98.87 |
| Cardiovascular Disease and Adiposity | Lifetime | 168 | US 99 | 99.06 |
| Cardiovascular Health and Disease Prevention | Lifetime | 212 | US 100 | 98.81 |
| Mesenchymal stem cell research | Lifetime | 233 | US 95 | 98.67 |
| Aortic aneurysm repair treatments | Lifetime | 220 | US 128 | 98.49 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 211 | US 95 | 98.32 |
| Acute Kidney Injury Research | Lifetime | 152 | US 71 | 98.16 |
| Cardiac Imaging and Diagnostics | Lifetime | 903 | US 442 | 98.66 |
| Pediatric Urology and Nephrology Studies | Lifetime | 333 | US 190 | 97.87 |
| Blood Pressure and Hypertension Studies | Lifetime | 626 | US 259 | 98.25 |
| Chronic Kidney Disease and Diabetes | Lifetime | 301 | US 136 | 98.33 |
| Vascular anomalies and interventions | Lifetime | 245 | US 152 | 96.76 |
| Coronary Interventions and Diagnostics | Lifetime | 862 | US 343 | 97.68 |
| Renal cell carcinoma treatment | Lifetime | 784 | US 397 | 97.00 |
| Lipoproteins and Cardiovascular Health | Lifetime | 782 | US 335 | 96.98 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 993 | US 375 | 95.58 |
| Organ Donation and Transplantation | Lifetime | 995 | US 470 | 94.10 |
| Biomarkers in Disease Mechanisms | Lifetime | 352 | US 98 | 89.75 |
| Renin-Angiotensin System Studies | Lifetime | 930 | US 355 | 92.90 |
| GDF15 and Related Biomarkers | Lifetime | 262 | US 93 | 88.43 |
| Renal and Vascular Pathologies | 2021-2025 | 7 | US 2 | 99.25 |
| Tissue Engineering and Regenerative Medicine | 2021-2025 | 59 | US 11 | 96.58 |
| Mesenchymal stem cell research | 2021-2025 | 71 | US 13 | 96.39 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 303 | US 86 | 90.42 |
| Renal cell carcinoma treatment | 2021-2025 | 998 | US 314 | 87.71 |
| Renal and related cancers | 2021-2025 | 729 | US 274 | 83.80 |
| Aortic aneurysm repair treatments | 2021-2025 | 878 | US 284 | 85.81 |
| Vascular anomalies and interventions | 2021-2025 | 320 | US 113 | 70.51 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 953 | US 90 | 32.52 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 785 | US 48 | 19.41 |
